References
- Walker M D, Green S B, Bvar D P. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant gliomas after surgery. N Engl J Med 1980; 303: 1323–9
- The Brain Tumor Cooperative Group. Results of a radomized trial comparing BCNU plus radiotheraphy, streptozotocin plus radiotherphy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Int J Radiat Oncol Biol Phys 1989; 16: 1389–96
- Rosenblum M L, Gerosa M A, Bodell W J, Talcott R L. Tumor cell resistance. Prog Exp Tumor Res 1984; 27: 191–214
- Mineura K, Fushimi S, Itoh Y, Kowada M. DNA lability induced by nimustine (ACNU) and ramustine (MCNU) in rat glioma cell. J Neurol Neurosurg Psychiat 1988; 51: 1391–4
- Wiestler O, Kleihues P, Pegg A E. O6-alkylguanine-DNA alkyltransferase activity in human brain and brain tumors. Carcinogenesis 1984; 5: 121–4
- Schold S C, Brent T P, von Hofe E. O6-alkylguanine-DNA-alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts. J Neurosurg 1989; 70: 573–7
- Ziilch K G. Histological typing of tumors of the central nervous system. World Health Organization, Geneva 1979
- Mineura K, Fushimi S, Kowada M, Isowa G, Ishizaki K, Ikenaga M. Linkage between O6-methylguanine-DNA methyltransferase activity and cellular resistance to antitumor nitrosoureas in cultured rat brain tumor cell stains. Acta Neuochir (Wein) 1990; 103: 62–6
- Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–75
- Fine H, Dear K, Loeffler J, Ganellos G. Meta-analysis of radiotheraphy with and without adjuvant chemotherapy for malignant gliomas in adults. Proc Am Soc Clin Oncol 1991; 19: 125
- Kornblith P L, Smith B H, Leonard L A. Response of cultured human brain tumors to nitrosoureas. Correlation with clinical data. Cancer 1981; 47: 255–65
- Tsujimura T, Zhang Y, Fujio C. O6-methylguanine methyltransferase activity and sensitivity of Japanese tumor cell strains to l-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride. Jpn J Cancer Res 1987; 78: 1207–15
- Fujio C, Chang H R, Tsujimura T, Ishizaki K, Kitamura H, Ikenaga M. Hypersenstivity of human tumor xenografts lacking O6-methylguanine-DNA alkyltransferase to the anti-tumor agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea. Carcinogenesis 1989; 10: 351–6
- Mineura K, Kuwahara N, Watanabe K, Kowada M. O6-methylguanine-DNA methyltransferase (O6-MT) activity as an index of drug responsiveness to antitumor chloroethyl-nitrosoureas in xenografted brain tumors. Biological aspects of brain tumors, K Tabuchi. Springer-Verlag, Tokyo 1991; 266–72